Conventional reference genes such as GAPDH, TBP, or miR-16-5p, frequently chosen based on historical usage rather than empirical evidence, show considerable variability in contexts like cancer, metabolic disorders, and biofluids prone to hemolysis. This evidence concerns the gene TBP and cancer.